Fairhaven Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,899
| Closed | -$218K | – | 125 |
|
|
2024
Q3 | $218K | Hold |
1,899
| – | – | 0.07% | 110 |
|
|
2024
Q2 | $202K | Buy |
+1,899
| New | +$202K | 0.07% | 109 |
|
|
2023
Q4 | – | Sell |
-1,969
| Closed | -$201K | – | 122 |
|
|
2023
Q3 | $201K | Buy |
+1,969
| New | +$201K | 0.08% | 102 |
|
|
2022
Q4 | $210K | Buy |
+2,309
| New | +$210K | 0.09% | 99 |
|
|
2022
Q3 | – | Sell |
-2,691
| Closed | -$227K | – | 121 |
|
|
2022
Q2 | $227K | Sell |
2,691
-2,190
| -45% | -$185K | 0.11% | 93 |
|
|
2022
Q1 | $428K | Sell |
4,881
-15,414
| -76% | -$1.35M | 0.17% | 64 |
|
|
2021
Q4 | $1.78M | Sell |
20,295
-7,000
| -26% | -$612K | 0.69% | 33 |
|
|
2021
Q3 | $2.23M | Buy |
27,295
+3,814
| +16% | +$312K | 0.92% | 32 |
|
|
2021
Q2 | $2.14M | Buy |
23,481
+1,438
| +7% | +$131K | 0.85% | 33 |
|
|
2021
Q1 | $1.88M | Buy |
22,043
+6,593
| +43% | +$563K | 0.79% | 35 |
|
|
2020
Q4 | $1.46M | Buy |
15,450
+3,080
| +25% | +$291K | 0.64% | 39 |
|
|
2020
Q3 | $1.08M | Buy |
12,370
+3,159
| +34% | +$275K | 0.64% | 35 |
|
|
2020
Q2 | $804K | Buy |
9,211
+2,017
| +28% | +$176K | 0.53% | 40 |
|
|
2020
Q1 | $593K | Buy |
7,194
+1,777
| +33% | +$146K | 0.54% | 35 |
|
|
2019
Q4 | $513K | Hold |
5,417
| – | – | 0.43% | 37 |
|
|
2019
Q3 | $471K | Buy |
5,417
+145
| +3% | +$12.6K | 0.44% | 35 |
|
|
2019
Q2 | $481K | Buy |
5,272
+489
| +10% | +$44.6K | 0.45% | 35 |
|
|
2019
Q1 | $412K | Buy |
4,783
+402
| +9% | +$34.6K | 0.39% | 39 |
|
|
2018
Q4 | $337K | Buy |
+4,381
| New | +$337K | 0.33% | 42 |
|